Related Experiment Video
Updated: Jun 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Simultaneous confidence bands for nonlinear regression models with application to population pharmacokinetic analyses
1Novartis Pharma AG, Basel, Switzerland. sandro.gsteiger@novartis.com
This study introduces two new methods for constructing simultaneous confidence bands in nonlinear mixed-effects models, crucial for accurate biostatistical analysis and dose-response modeling.
Area of Science:
- Biostatistics
- Pharmacometrics
- Statistical Modeling
Background:
- Nonlinear regression models are vital in biostatistics, particularly for population pharmacokinetic and pharmacodynamic (PK/PD) modeling.
- Pointwise confidence intervals are insufficient for simultaneous inference across the entire covariate region.
- Existing methods can lead to reduced coverage probability when assessing the whole covariate range.
Purpose of the Study:
- To develop and evaluate methods for constructing simultaneous confidence bands for mean profiles in nonlinear mixed-effects models.
- To address the limitations of pointwise confidence intervals for comprehensive covariate region assessment.
- To provide tools for reliable inference in dose-response and biosimilarity applications.
Main Methods:
- Proposed two large-sample methods for simultaneous confidence band construction.
- Method 1: Based on the Schwarz inequality and asymptotic chi-squared distribution.
- Method 2: Utilizes simulation from a multivariate normal distribution.
Main Results:
- The study illustrates the application of these methods using theophylline pharmacokinetics data.
- An extensive simulation study was conducted to assess the operating characteristics of the proposed methods.
- The methods were extended for simultaneous confidence bands of model differences and for assessing model equivalence in biosimilarity.
Conclusions:
- The developed methods provide a statistically sound approach for simultaneous inference over the covariate region in nonlinear mixed-effects models.
- These methods enhance the reliability of analyses in pharmacometrics and related biostatistical fields.
- The extensions facilitate robust comparisons and equivalence assessments between models, particularly relevant for biosimilarity evaluations.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
